Brand name: Aspirin (Pharmacy Choice) TM
Active ingredients: aspirin
What it is used for
For the temporary relief from pain associated with headaches and migraine headaches, rheumatic and arthritic pain, fibrositis, neuralgia, toothache, cold and flu sysmptoms, sore throats and period pain. Relieves inflammation associated with back and muscular pain, strains and sprains. Reduces fever.
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
- The way to take this medicine: Oral
- Store below 25 degrees Celsius
- Lifetime is 36 Months.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
White uncoated circular biconvex tablets, wth deep score on one side and plain on other side
Do I need a prescription?
We are unable to tell you if you need a prescription for this medicine. You can ask your pharmacist.This medicine is
Over 65?
This medicine contains the active ingredients:
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
Pregnant or planning a pregnancy?
For the active ingredient aspirin
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Need more information?
These trusted information partners have more on this topic.
Top results
Piax Plus Aspirin Tablets - myDr.com.au
Piax Plus Aspirin Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Clopidogrel Winthrop Plus Aspirin Tablets - myDr.com.au
Clopidogrel Winthrop Plus Aspirin Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Clopidogrel/Aspirin Actavis 75/100 Tablets - myDr.com.au
Clopidogrel/Aspirin Actavis 75/100 Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Clopidogrel/Aspirin Sandoz 75/100 Tablets - myDr.com.au
Clopidogrel/Aspirin Sandoz 75/100 Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
APO-Dipyridamole/Aspirin Modified release capsules - myDr.com.au
APO-Dipyridamole/Aspirin Modified release capsules - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Extemporaneously compounded medicines | Issue 1 | Volume 40 | Australian Prescriber
Compounded medicines are not generally assessed for safety and efficacy. Read more about their regulation and short-term expiry dates.
Read more on Australian Prescriber website
Whooping cough self-care - myDr.com.au
Whooping cough is an infection caused by bacteria, is more common in children under 5 years, and can have serious consequences. Find out what products are available for whooping cough.
Read more on myDr website
Platelet function tests - Lab Tests Online AU
Platelets are vital for normal blood clotting
Read more on Lab Tests Online website
Astrix 100 Capsules - myDr.com.au
Astrix 100 Capsules - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Diasp SR Sustained release capsules - myDr.com.au
Diasp SR Sustained release capsules - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Top results
Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease | Cochrane
Low-dose aspirin as antiplatelet therapy is still the drug of choice for preventing cardiovascular events, but the protection aspirin gives to people at high risk of cardiovascular events is only relatively modest. This review of 28,165 people in two trials where clopidogrel was given in addition to antiplatelet treatment found that in patients with acute coronary syndromes the benefit - a reduction in cardiovascular events - outweighs the harm of major bleeding. However, clopidogrel plus aspirin has no clear positive risk-benefit profile in people at high risk of cardiovascular events (multiple atherothrombotic risk factors) or in people with established cardiovascular disease (known coronary disease, ischemic cerebrovascular disease or peripheral arterial disease) but not presenting with an acute coronary syndrome, and the combination should not be prescribed routinely to prevent cardiovascular disease.
Read more on Cochrane (Australasian Centre) website
Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients | Cochrane
Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients
Read more on Cochrane (Australasian Centre) website
Antiplatelet drugs for preventing arterial and venous thrombotic events in patients with polycythaemia vera or essential thrombocythaemia | Cochrane
Antiplatelet drugs for preventing arterial and venous thrombotic events in patients with polycythaemia vera or essential thrombocythaemia
Read more on Cochrane (Australasian Centre) website
New antiplatelet drugs | Issue 6 | Volume 37 | Australian Prescriber
Dentists should be familiar with clopidogrel, which is commonly used in combination with aspirin following placement of coronary stents to prevent coronary...
Read more on Australian Prescriber website
Prescribing for people with acute rheumatic fever | Issue 2 | Volume 40 | Australian Prescriber | Australian Prescriber
Check out the recent changes in Australian recommendations for antibiotic use, aspirin dose and prevention of endocarditis.
Read more on Australian Prescriber website
Evidence on interventions for paracetamol (acetaminophen) overdose patients is weak | Cochrane
Poisoning with paracetamol (acetaminophen) is a common cause of hepatic injury. The evidence for all interventions for paracetamol overdose is weak. Activated charcoal, gastric lavage, and ipecacuanha are able to reduce absorption of paracetamol if started within one to two hours of paracetamol ingestion, but the clinical benefit is unclear. Activated charcoal seems to be the best choice if the patient is compliant. N-acetylcysteine seems superior to no intervention and other antidotes (dimercaprol, cysteamine) and should be administered to patients at significant risk of hepatic damage. However, N-acetylcysteine superiority to methionine is unclear. Liver transplantation will clearly benefit patients with irreversible hepatic failure. However, identifying such patients early is problematic and the long-term outcomes in this group of patients have not been reported. Other interventions have not shown any clinical benefit for paracetamol overdose.
Read more on Cochrane (Australasian Centre) website
Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks | Cochrane
Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks
Read more on Cochrane (Australasian Centre) website
Oral painkillers available without prescription for acute pain | Cochrane
Acute pain is often felt soon after injury, and is of short duration. Most people who have surgery have moderate or severe pain afterwards. Painkillers (analgesics) are tested in people with pain, often following the removal of wisdom teeth. Study participants have to have at least moderate pain levels and the pain is usually treated with painkillers taken by mouth. This overview is useful mainly for acute pain lasting only a few days or weeks, and not for chronic pain lasting for many months. For this overview we have not included information from reviews on migraine, tension headache, or period pain.
Read more on Cochrane (Australasian Centre) website
Chuanxiong preparations to prevent stroke in people at high risk of stroke | Cochrane
Read more on Cochrane (Australasian Centre) website
Peptic ulcer disease and non-steroidal anti-inflammatory drugs | Issue 3 | Volume 40 | Australian Prescriber | Australian Prescriber
Find out the top 5 risk factors for gastrointestinal toxicity with NSAIDs and how to minimise these adverse effects.
Read more on Australian Prescriber website
